Disclosed is a biodegradable resin composite material including a biodegradable polymer resin and multifunctional particles, wherein: (a) the multifunctional particles include 10-70 wt. % of a hydrophobic active ingredient, 21-72 wt. % of a polysaccharide, 3.80-20 wt. % of a crosslinking agent, 1.00-6 wt. % of a catalyst, 0.10-5 wt. % of a silica flow aid, optionally 0.10-5 wt. % of a desiccant, optionally 0.20-20 wt. % emulsifier, optionally 1-10 wt. % of a degradation enhancer, and optionally 1-10 wt. % of particle dispersion aids; (b) the multifunctional particles are anhydrous; and (c) the hydrophobic active ingredient is encapsulated in a crosslinked polysaccharide matrix. Alternative multifunctional particles useful in the invention are also disclosed.

Disclosed is a biodegradable resin composite material including a biodegradable polymer resin and multifunctional particles, wherein: (a) the multifunctional particles include 10-70 wt. % of a hydrophobic active ingredient, 21-72 wt. % of a polysaccharide, 3.80-20 wt. % of a crosslinking agent, 1.00-6 wt. % of a catalyst, 0.10-5 wt. % of a silica flow aid, optionally 0.10-5 wt. % of a desiccant, optionally 0.20-20 wt. % emulsifier, optionally 1-10 wt. % of a degradation enhancer, and optionally 1-10 wt. % of particle dispersion aids; (b) the multifunctional particles are anhydrous; and (c) the hydrophobic active ingredient is encapsulated in a crosslinked polysaccharide matrix. Alternative multifunctional particles useful in the invention are also disclosed.

Described herein is a three-dimensional platform delivery technology including a polymeric material.

Described herein is a three-dimensional platform delivery technology including a polymeric material.

This application relates to a stent inserted in an eustachian tube for treatment of eustachian tube dysfunction. In one aspect, the stent includes a pressure controller which blocks the eustachian tube and is opened/closed according to a pressure difference between front and rear portions thereof to control a pressure in the eustachian tube. The stent may also include a eustachian tube expansion portion which is connected to the pressure controller and has a hollow portion passed therein to make a fluid move in back and forth directions of the eustachian tube, and is inserted in the eustachian tube to expand the eustachian tube by transforming a shape thereof in a radial direction of the eustachian tube.

This application relates to a stent inserted in an eustachian tube for treatment of eustachian tube dysfunction. In one aspect, the stent includes a pressure controller which blocks the eustachian tube and is opened/closed according to a pressure difference between front and rear portions thereof to control a pressure in the eustachian tube. The stent may also include a eustachian tube expansion portion which is connected to the pressure controller and has a hollow portion passed therein to make a fluid move in back and forth directions of the eustachian tube, and is inserted in the eustachian tube to expand the eustachian tube by transforming a shape thereof in a radial direction of the eustachian tube.

The present invention is directed to compositions containing polymer matrix, fiber and/or additives which are suitable for load bearing applications for medical devices. The matrix can be formed from a group of polymers which resorb inside the body after implantation. These compositions contain reinforcing fibers that are incorporated into a resorbable polymer matrix to improve properties such as mechanical. The reinforcing fibers can be resorbable, non-resorbable, natural, or metallic. Additives can be incorporated into the matrix material or the fibers or both to provide a secondary effect. These additives can be bioceramics to provide an osteoconductive effect; antimicrobial particles such as silver; coloring agents, and radiopaque additives to make the implants visible under fluoroscopy. The additives may also contribute to improve mechanical properties. The Composite composition with Matrix, Fibers and/or additives can provide enhanced functionality of mechanical, Osteoconductive and tailored degradation characteristics that can result in superior properties conventionally not achievable for Bioresorbable composites.

The present invention is directed to compositions containing polymer matrix, fiber and/or additives which are suitable for load bearing applications for medical devices. The matrix can be formed from a group of polymers which resorb inside the body after implantation. These compositions contain reinforcing fibers that are incorporated into a resorbable polymer matrix to improve properties such as mechanical. The reinforcing fibers can be resorbable, non-resorbable, natural, or metallic. Additives can be incorporated into the matrix material or the fibers or both to provide a secondary effect. These additives can be bioceramics to provide an osteoconductive effect; antimicrobial particles such as silver; coloring agents, and radiopaque additives to make the implants visible under fluoroscopy. The additives may also contribute to improve mechanical properties. The Composite composition with Matrix, Fibers and/or additives can provide enhanced functionality of mechanical, Osteoconductive and tailored degradation characteristics that can result in superior properties conventionally not achievable for Bioresorbable composites.

A method for producing an intraluminal endoprosthesis. The method forms a sheath on a support structure of the endoprosthesis from polymer fibres. A polymer solution is dispensed from a nozzle by f electrospinning. The polymer solution includes at least one biodegradable polymer polymer and at least one additive. The additive is selected from the group consisting of: 1,3-dioxan-2-one, 1,4-dioxan-2-one, triethyl citrate, glycerol triacetate, n-butyryl tri-n-hexyl citrate, polyethylene glycol, L-α phosphatidylcholine.

A method for producing an intraluminal endoprosthesis. The method forms a sheath on a support structure of the endoprosthesis from polymer fibres. A polymer solution is dispensed from a nozzle by f electrospinning. The polymer solution includes at least one biodegradable polymer polymer and at least one additive. The additive is selected from the group consisting of: 1,3-dioxan-2-one, 1,4-dioxan-2-one, triethyl citrate, glycerol triacetate, n-butyryl tri-n-hexyl citrate, polyethylene glycol, L-α phosphatidylcholine.